Your browser doesn't support javascript.
loading
Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment.
Stavrou, Victoria; Fultang, Livingstone; Booth, Sarah; De Simone, Daniele; Bartnik, Arekdiusz; Scarpa, Ugo; Gneo, Luciana; Panetti, Silvia; Potluri, Sandeep; Almowaled, Meaad; Barlow, Jonathan; Jankevics, Andris; Lloyd, Gavin; Southam, Andrew; Priestman, David A; Cheng, Paul; Dunn, Warwick; Platt, Frances; Endou, Hitoshi; Craddock, Charles; Keeshan, Karen; Mussai, Francis; De Santo, Carmela.
Afiliação
  • Stavrou V; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Fultang L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Booth S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • De Simone D; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Bartnik A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Scarpa U; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Gneo L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Panetti S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Potluri S; Institute of Cancer and Genomics, University of Birmingham, Birmingham, B15 2TT, UK.
  • Almowaled M; Paul O'Gorman Leukaemia Research Centre, University of Glasgow, Glasgow, G12 0YN, UK.
  • Barlow J; School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, B15 2TT, UK.
  • Jankevics A; School of Biosciences and Phenome Centre Birmingham, University of Birmingham, Birmingham, B15 2TT, UK.
  • Lloyd G; School of Biosciences and Phenome Centre Birmingham, University of Birmingham, Birmingham, B15 2TT, UK.
  • Southam A; School of Biosciences and Phenome Centre Birmingham, University of Birmingham, Birmingham, B15 2TT, UK.
  • Priestman DA; Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK.
  • Cheng P; Bio-Cancer Treatment International, Hong Kong Science Park, Hong Kong, China.
  • Dunn W; Institute of Cancer and Genomics, University of Birmingham, Birmingham, B15 2TT, UK.
  • Platt F; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, B15 2TT, UK.
  • Endou H; Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK.
  • Craddock C; J-Pharma Co. Ltd, Yokohama, Kanagawa, 230-0046, Japan.
  • Keeshan K; Institute of Cancer and Genomics, University of Birmingham, Birmingham, B15 2TT, UK.
  • Mussai F; Paul O'Gorman Leukaemia Research Centre, University of Glasgow, Glasgow, G12 0YN, UK.
  • De Santo C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK. francis.mussai@nhs.net.
Cancer Immunol Immunother ; 72(3): 543-560, 2023 Mar.
Article em En | MEDLINE | ID: mdl-35962843
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Células T Matadoras Naturais / Células Supressoras Mieloides Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Células T Matadoras Naturais / Células Supressoras Mieloides Idioma: En Ano de publicação: 2023 Tipo de documento: Article